Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Interstitial and orphan lung disease

  • Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
    Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
    ERJ Open Research Oct 2022, 8 (4) 00337-2022; DOI: 10.1183/23120541.00337-2022
  • Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan
    Hirokazu Urushiyama, Taisuke Jo, Wakae Hasegawa, Akira Yokoyama, Takahiro Ando, Yukiyo Sakamoto, Ryosuke Kumazawa, Kazuaki Uda, Nobuaki Michihata, Nobuyasu Awano, Matsui Hiroki, Kiyohide Fushimi, Hideo Yasunaga, Takahide Nagase
    ERJ Open Research Oct 2022, 8 (4) 00209-2022; DOI: 10.1183/23120541.00209-2022
  • Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
    Sebastiaan Dhont, Bert Zwaenepoel, Els Vandecasteele, Guy Brusselle, Michel De Pauw
    ERJ Open Research Oct 2022, 8 (4) 00272-2022; DOI: 10.1183/23120541.00272-2022
  • Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra
    Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba
    ERJ Open Research Oct 2022, 8 (4) 00245-2022; DOI: 10.1183/23120541.00245-2022
  • Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis
    Toby M. Maher, Christina Schlecker, Doreen Luedtke, Sebastian Bossert, Donald F. Zoz, Armin Schultz
    ERJ Open Research Oct 2022, 8 (4) 00240-2022; DOI: 10.1183/23120541.00240-2022
  • Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis
    Jade Jaffar, Mae Wong, Gregory A. Fishbein, Monther Alhamdoosh, Laura McMillan, Cristina Gamell-Fulla, Milica Ng, Nick Wilson, Karen Symons, Ian Glaspole, Glen Westall
    ERJ Open Research Oct 2022, 8 (4) 00191-2022; DOI: 10.1183/23120541.00191-2022
  • Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosis
    Gillian C. Goobie, Christopher J. Ryerson, Kerri A. Johannson, Spencer Keil, Erin Schikowski, Nasreen Khalil, Veronica Marcoux, Deborah Assayag, Hélène Manganas, Jolene H. Fisher, Martin R.J. Kolb, Xiaoping Chen, Kevin F. Gibson, Daniel J. Kass, Yingze Zhang, Kathleen O. Lindell, S. Mehdi Nouraie
    ERJ Open Research Oct 2022, 8 (4) 00357-2022; DOI: 10.1183/23120541.00357-2022
  • Functional clinical impairments and frailty in interstitial lung disease patients
    Pierre-François Tremblay Labrecque, Geneviève Dion, Didier Saey
    ERJ Open Research Oct 2022, 8 (4) 00144-2022; DOI: 10.1183/23120541.00144-2022
  • Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort
    Heba M. Bintalib, David M. Lowe, Gaia Mancuso, Georgia Gkrepi, Suranjith L. Seneviratne, Siobhan O. Burns, John R. Hurst
    ERJ Open Research Oct 2022, 8 (4) 00024-2022; DOI: 10.1183/23120541.00024-2022
  • Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
    Toru Arai, Yoshikazu Inoue
    ERJ Open Research Jul 2022, 8 (3) 00242-2022; DOI: 10.1183/23120541.00242-2022

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 21
  • Acute lung injury and critical care (52)
  • Asthma and allergy (269)
  • CF and non-CF bronchiectasis (158)
  • COPD and smoking (404)
  • Epidemiology, occupational and environmental lung disease (67)
  • Genetics (33)
  • Interstitial and orphan lung disease (209)
  • Lung biology and experimental studies (97)
  • Lung cancer (87)
  • Lung imaging (73)
  • Lung structure and function (129)
  • Mechanisms of lung disease (5)
  • Paediatric pulmonology (125)
  • Pulmonary pharmacology and therapeutics (158)
  • Pulmonary vascular disease (107)
  • Respiratory clinical practice (99)
  • Respiratory infections and tuberculosis (407)
  • Sleep medicine (67)
  • Most Read
  • Twitter
Loading
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Effects of inspiratory muscle training on exertional breathlessness in patients with unilateral diaphragm dysfunction: a randomised trial
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Type 2 inflammation in asthma and other airway diseases
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society